
Benzinga Pro data, Oak Street Health (NYSE:OSH) reported Q4 sales of $394.10 million. Earnings fell to a loss of $140.30 million, resulting in a 27.66% decrease from last quarter. Oak Street Health collected $388.70 million in revenue during Q3, but reported earnings showed a $109.90 million loss.